GL1X · GenesisL1 explorer

Research workbench

Crystal structure of inhibitor jnj-36689282 in complex with prefusion rsv F glycoprotein

Analyse Crystal structure of inhibitor jnj-36689282 in complex with prefusion rsv F… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6VKD
Type
protein
Length
441 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Prefusion rsv F (ds-CAV1)
UniProt
W8RJF9, M1E1E4
Ligands
R0P, SO4, CL
Pockets
2 · best druggability 0.30

Structure

x-ray diffraction · 1 distinct chain · 31% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
FPrefusion rsv F (ds-CAV1)protein44131% helix, 34% strandW8RJF9, M1E1E4

Ligands and binding sites

  • R0P · 1-cyclopropyl-3-({1-[3-(methylsulfonyl)propyl]-1H-pyrrolo[3,2-c]pyridin-2-yl}methyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one · ligand · chains F
  • SO4 · Sulfate ion · ion · 6 copies · chains F
  • CL · Chloride ion · ion · chains F

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1570.300.7515empty
2530.270.7513empty

Modifications

Observed in the structure: 7 disulfide (disulfide).

Compared structures

  • 6VKD · Crystal Structure of Inhibitor JNJ-36689282 in Complex with Prefusion RSV F Glycoprotein · the same entry in another collection · chain F against F, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.